<p>Phase contrast images of (<b>A</b>) Undamaged cells (<b>B</b>) Cells exposed to 6% CSE at low volume (3 mL) (<b>C</b>) Cells exposed to 8% CSE at low volume (<b>D</b>) A scatterplot illustrating the general upward trend in expression of cellular cytotoxicity biomarkers at both CSE concentrations (6%, 8%) at either low volume (LV) or high volume (HV) (please see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0163182#pone.0163182.t002" target="_blank">Table 2</a> for more details) (<b>E</b>) Cells exposed to 6% CSE at high volume (6 mL) (<b>F</b>) Cells exposed to 8% CSE at high volume.</p
<p>(<b>A</b>) Distribution of viable, early apoptotic, late apoptotic and necrotic cells analysed by...
<p><b>(A)</b> Representative micrographs of cells with the indicated genotypes at the indicated time...
<p>A. Percentage of iNKT cells (TCRβ<sup>+</sup> CD1d tetramer<sup>+</sup>) in CD45<sup>+</sup> cell...
<p>Phase contrast images of (<b>A</b>) Undamaged cells (<b>B</b>) Cells exposed to 6% CSE at low vol...
<p>The supernatants of CSE-exposed cDCs were tested for the production and release of CCL3 (A) and C...
<p>(<b>A</b>) NIH 3T3 mouse fibroblasts were plated at 10,000, 15,000, or 20,000 cells/well in a 48 ...
<p>(<b>A</b>) Confocal images of immunostaining of bcl-xl (left panel) and cell cycle regulator prot...
<p>Analysis of HeLa cells after 96 h of treatment. (A) Representative actin stained images of DMSO c...
<p>(<b>A</b>) Phase contrast photomicrographs of U87MG, HeLa, PC3 and C6 cell lines treated with TCE...
<p>(<b>A</b>) Morphology and SA-ß-Gal activity of untreated human RPE cells. Only single cells were ...
<p><b>A.</b> MTT assay for cell toxicity was performed on confluent HCLE cells. The response to cont...
<p>SKOV3 wildtype (A) and transfection control (empty vector) SKOV3(-) cells (C5 (B) and C6 (C)) sho...
<p>A-C. Effect of CSE on hASM cell proliferation. A) Using fluorescent Cyquant proliferation assay, ...
<p>A) Flow cytometry histogram of Bcl-2 (Ser 70) relative quantity (FL3-log) in vehicle-treated and ...
<p>(A) Experimental setup. Proliferating HEL fibroblasts were treated with sublethal doses of doxoru...
<p>(<b>A</b>) Distribution of viable, early apoptotic, late apoptotic and necrotic cells analysed by...
<p><b>(A)</b> Representative micrographs of cells with the indicated genotypes at the indicated time...
<p>A. Percentage of iNKT cells (TCRβ<sup>+</sup> CD1d tetramer<sup>+</sup>) in CD45<sup>+</sup> cell...
<p>Phase contrast images of (<b>A</b>) Undamaged cells (<b>B</b>) Cells exposed to 6% CSE at low vol...
<p>The supernatants of CSE-exposed cDCs were tested for the production and release of CCL3 (A) and C...
<p>(<b>A</b>) NIH 3T3 mouse fibroblasts were plated at 10,000, 15,000, or 20,000 cells/well in a 48 ...
<p>(<b>A</b>) Confocal images of immunostaining of bcl-xl (left panel) and cell cycle regulator prot...
<p>Analysis of HeLa cells after 96 h of treatment. (A) Representative actin stained images of DMSO c...
<p>(<b>A</b>) Phase contrast photomicrographs of U87MG, HeLa, PC3 and C6 cell lines treated with TCE...
<p>(<b>A</b>) Morphology and SA-ß-Gal activity of untreated human RPE cells. Only single cells were ...
<p><b>A.</b> MTT assay for cell toxicity was performed on confluent HCLE cells. The response to cont...
<p>SKOV3 wildtype (A) and transfection control (empty vector) SKOV3(-) cells (C5 (B) and C6 (C)) sho...
<p>A-C. Effect of CSE on hASM cell proliferation. A) Using fluorescent Cyquant proliferation assay, ...
<p>A) Flow cytometry histogram of Bcl-2 (Ser 70) relative quantity (FL3-log) in vehicle-treated and ...
<p>(A) Experimental setup. Proliferating HEL fibroblasts were treated with sublethal doses of doxoru...
<p>(<b>A</b>) Distribution of viable, early apoptotic, late apoptotic and necrotic cells analysed by...
<p><b>(A)</b> Representative micrographs of cells with the indicated genotypes at the indicated time...
<p>A. Percentage of iNKT cells (TCRβ<sup>+</sup> CD1d tetramer<sup>+</sup>) in CD45<sup>+</sup> cell...